These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 21171894

  • 1. Apixaban inhibition of factor Xa: Microscopic rate constants and inhibition mechanism in purified protein systems and in human plasma.
    Luettgen JM, Knabb RM, He K, Pinto DJ, Rendina AR.
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):514-26. PubMed ID: 21171894
    [Abstract] [Full Text] [Related]

  • 2. Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
    Becker RC, Alexander JH, Newby LK, Yang H, Barrett Y, Mohan P, Wang J, Harrington RA, Wallentin LC.
    Thromb Haemost; 2010 Nov; 104(5):976-83. PubMed ID: 20806117
    [Abstract] [Full Text] [Related]

  • 3. Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro.
    Jiang X, Crain EJ, Luettgen JM, Schumacher WA, Wong PC.
    Thromb Haemost; 2009 Apr; 101(4):780-2. PubMed ID: 19350128
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study.
    Gouin-Thibault I, Flaujac C, Delavenne X, Quenet S, Horellou MH, Laporte S, Siguret V, Lecompte T.
    Thromb Haemost; 2014 Feb; 111(2):240-8. PubMed ID: 24172843
    [Abstract] [Full Text] [Related]

  • 8. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA, Lormeau JC, Craven S, Dewar L, Anvari N.
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [Abstract] [Full Text] [Related]

  • 9. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM, Kalafatis M, Tracy PB.
    Biochemistry; 1998 Aug 25; 37(34):11896-906. PubMed ID: 9718313
    [Abstract] [Full Text] [Related]

  • 10. [Apixaban: pharmacology and action profile].
    Gassanov N, Caglayan E, Er F.
    Dtsch Med Wochenschr; 2012 Jan 25; 137(4):138-41. PubMed ID: 22259168
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A, Vlasuk GP, Bergum PW, Krishnaswamy S.
    Biochemistry; 1997 Jan 07; 36(1):181-91. PubMed ID: 8993332
    [Abstract] [Full Text] [Related]

  • 12. Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties.
    Orwat MJ, Qiao JX, He K, Rendina AR, Luettgen JM, Rossi KA, Xin B, Knabb RM, Wexler RR, Lam PY, Pinto DJ.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3341-5. PubMed ID: 24951330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of prothrombinase activity by protein S.
    van 't Veer C, Butenas S, Golden NJ, Mann KG.
    Thromb Haemost; 1999 Jul 01; 82(1):80-7. PubMed ID: 10456458
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Apixaban pharmacodynamic activity in umbilical cord, paediatric, and adult plasma.
    Yetman RJ, Barrett YC, Wang Z, Adamczyk R, Wang J, Ramacciotti E, Frost C.
    Thromb Haemost; 2017 Jul 26; 117(8):1518-1527. PubMed ID: 28536722
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.